Sensitech Completes Acquisition of Berlinger & Co. Monitoring Solutions Expanding Life Sciences Cold Chain Solutions

BEVERLY, Mass., Aug. 2, 2024 /PRNewswire/ — Carrier Global Corporation, on behalf of its Sensitech business, a world leader in supply chain visibility, has completed its acquisition of the Monitoring Solutions business of Berlinger & Co. AG, a Swiss family-owned company that specializes in innovative and customized solutions for monitoring temperature-sensitive goods in the pharmaceutical and life science, clinical trial and global health segments. Sensitech is part of Carrier Global Corporation (NYSE: CARR), global leader in intelligent climate and energy solutions.

“This successful acquisition marks a strategic milestone for Sensitech, creating comprehensive and differentiated cold chain monitoring and visibility solutions for the pharma and life sciences industry,” said Bhasker Kaushal, Vice President & General Manager, Sensitech and Refrigeration Aftermarket. “We are excited to welcome the Berlinger team as our new colleagues and look forward to bringing together the best of Berlinger and Sensitech to enable our customers’ cold chains to become more connected, automated, intelligent and sustainable.”

Berlinger expands Sensitech’s end-to-end cold chain monitoring portfolio with a suite of innovative solutions, including high-quality proprietary conventional and real-time monitoring, value-added software and analytics capabilities. Additionally, it broadens Sensitech’s addressable market reach into adjacent segments of stationary monitoring and global health.

The Monitoring Solutions business of Berlinger includes approximately 85 employees operating in Switzerland, the Netherlands and the United States.

Lenz & Staehelin provided external legal counsel in this transaction.

About Sensitech
Sensitech® is a world leader in supply chain visibility. Our innovative monitoring products and services help to maintain the quality and integrity of our customers’ valuable products at every step in their journey, all around the world. For 30 years, leading companies in the food, pharmaceutical, industrial, consumer goods, and other industries have relied on Sensitech to help protect their products. Sensitech is a part of Carrier Global Corporation, global leader in intelligent climate and energy solutions that matter for people and our planet for generations to come. For more information, visit Sensitech.com or follow Sensitech on Facebook at Sensitech Inc., on X @Sensitech and LinkedIn at Sensitech.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/sensitech-completes-acquisition-of-berlinger–co-monitoring-solutions-expanding-life-sciences-cold-chain-solutions-302212754.html

SOURCE Sensitech Inc.

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago